| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |